-+ 0.00%
-+ 0.00%
-+ 0.00%
Didactic, backed by GENEO Capital, buys Pearmine Health and Medadvance
Share
Listen to the news
Didactic, backed by GENEO Capital, buys Pearmine Health and Medadvance
  • Didactic acquired UK-based Pearmine Health and Germany-based Medadvance to accelerate international expansion in infectious disease prevention.
  • Pearmine adds manufacturing of wipes, impregnated gloves, oral hygiene solutions; Medadvance contributes European representation and distribution, strengthening Germany exposure.
  • Group revenue stands at EUR 90 million; headcount rises to 245 following the deal.
  • Transaction backed by long-term investors including Geneo Capital Entrepreneur and UI Investissement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Geneo Capital SAS published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending